The Recall Desk
ModerateFDA (Devices)·Z-1367-2014·Announced 2014-04-16

LumiQuick Drugs of Abuse Panel Test Device Recalled for Regulatory Violations

LumiQuick Diagnostics Inc. is recalling its Drugs of Abuse Panel Test Device because it was shipped to locations without required FDA approvals.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or specific health hazards, indicating a regulatory compliance issue rather than a direct safety threat.

Plain-English summary

LumiQuick Diagnostics Inc. is recalling its Drugs of Abuse Panel Test Device, catalog number 74007, all lots. The recall was initiated because the products were shipped to US locations that do not have approved applications for PMA, IDE, or 510(k) clearance.

The affected products were distributed in the states of California, Florida, New Jersey, Texas, and New York. The recall covers all units of the specified catalog number.

Consumers and healthcare providers who have purchased or received this product should stop using it and contact the manufacturer for further instructions.

The recalled product

Product
Drugs of Abuse Panel Test Device; LumiQuick. Santa Clara, CA 95054

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Catalog number: 74007
  • All lots

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 80 recalled by LumiQuick Diagnostics Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →

Same manufacturer · LumiQuick Diagnostics Inc.

See all →